Rapid Detection of Neisseria gonorrhoeae and Relevant Antimicrobial Resistance Targets

Nicole Ertl of the University of Queensland in Australia will develop a molecular test prototype for diagnosis of gonorrhea and antimicrobial resistance of the causative agent Neisseria gonorrhoeae. To increase access to testing, they will design the nucleic acid-based test to be rapid, inexpensive, and to work at ambient temperature without the need for electricity. The prototype platform will combine a sample preparation reagent requiring only short incubation at room temperature, chemically heated isothermal amplification, and lateral flow detection. It will incorporate detection of a relevant genetic signature to distinguish sensitivity versus resistance to the relevant drugs ceftriaxone and ciprofloxacin. They will evaluate the sensitivity and specificity of this sample-to-results platform and its usability in settings with minimal laboratory and testing infrastructure.